TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Swedish Orphan Biovitrum AB (publ)
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
26,841,583
|
22,411,301
|
17,773,699 |
| Financial expenses |
1,345,843
|
1,177,143
|
470,119 |
| Earnings before taxes |
4,544,929
|
2,992,496
|
3,141,376 |
| EBITDA |
9,641,601
|
7,328,271
|
5,757,770 |
| Total assets |
77,805,217
|
74,991,699
|
49,656,632 |
| Current assets |
13,573,939
|
12,836,125
|
10,604,627 |
| Current liabilities |
12,446,731
|
19,343,841
|
14,053,425 |
| Equity capital |
41,546,856
|
34,308,345
|
25,090,334 |
| - share capital |
201,103
|
196,528
|
160,805 |
| Employees (average) |
1,840
|
1,772
|
1,556 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
53.4%
|
45.7%
|
50.5% |
| Turnover per employee |
14,588
|
12,647
|
11,423 |
| Profit as a percentage of turnover |
16.9%
|
13.4%
|
17.7% |
| Return on assets (ROA) |
7.6%
|
5.6%
|
7.3% |
| Current ratio |
109.1%
|
66.4%
|
75.5% |
| Return on equity (ROE) |
10.9%
|
8.7%
|
12.5% |
| Change turnover |
4,026,186
|
3,376,435
|
3,084,621 |
| Change turnover % |
18%
|
18%
|
21% |
| Chg. No. of employees |
68
|
216
|
-3 |
| Chg. No. of employees % |
4%
|
14%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.